MK-0941

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for MK-0941, covering 2012-05-28 to 2012-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027) [Phase 1]